Nucs AI Expands Leadership Team to Enhance Prostate Cancer Care

Nucs AI has announced the expansion of its leadership team with the appointments of Andrew Findley as Chief of Staff, Dr. Jayashri Pawar as Medical Director, and Will Plogger as Vice President of Product, announced in a press release. These new leaders join co-founders CEO Nijat Ahmadov and CTO Farid Yagubbayli to further the company's mission of transforming prostate cancer diagnostics with AI-driven insights.

Andrew Findley brings strategic and operational expertise from his previous roles in healthcare technology and consulting, while Dr. Jayashri Pawar offers clinical rigor with her background in radiology and oncology. Will Plogger, with his experience in scaling AI medical imaging products, will focus on product development and clinical operations.

Nucs AI is committed to addressing the challenges in oncology by ensuring patients receive effective, targeted therapy. The company is building a Medical Advisory Board to provide critical insights into product development and clinical validation, aiming for regulatory clearance and wider adoption of its AI solutions in healthcare settings.